Trials / Active Not Recruiting
Active Not RecruitingNCT02793492
Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery
OSPREY ILIAC: Occlusive/Stenotic Peripheral Artery REvascularization StudY for Common and/or External ILIAC Artery Using the Misago® RX Self-expanding Peripheral Stent
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Terumo Medical Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Misago® RX Self-expanding Peripheral Stent | the Misago® RX Self-expanding Stent is a bare metal, nitinol stent |
Timeline
- Start date
- 2022-08-30
- Primary completion
- 2025-02-24
- Completion
- 2026-09-01
- First posted
- 2016-06-08
- Last updated
- 2026-03-25
Locations
9 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02793492. Inclusion in this directory is not an endorsement.